Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Breast cancer risk prediction models improved by adding multiple biological markers of risk

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.05.16
Views: 1538

Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA

Dr Xuehong Zhang presents his research at AACR 2016 on risk prediction models, of critical importance to patients evaluating their treatment options, and how to improve the prognostic accuracy of existing models based on novel biomarkers.

Dr Zhangs' modified models proved informative to patients and effective in shaping treatment decisions, especially for postmenopausal women not using hormone therapy (HT).

More on this can be found in the associate news article located here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation